Learn More
WRITING COMMITTEE MEMBERS* Glenn N. Levine, MD, FACC, FAHA, Chair, Eric R. Bates, MD, FACC, FAHA, Vice Chair*, James C. Blankenship, MD, FACC, FSCAI, Vice Chair*, Steven R. Bailey, MD, FACC, FSCAI*,(More)
Frederick G. Kushner, MD, FACC, FAHA, FSCAI, Co-Chair; Mary Hand, MSPH, RN, FAHA, Co-Chair*; Sidney C. Smith, Jr, MD, FACC, FAHA, Chair; Spencer B. King III, MD, MACC, FSCAI, Co-Chair; Jeffrey L.(More)
Glenn N. Levine, MD, FACC, FAHA, Chair†; Eric R. Bates, MD, FACC, FAHA, Vice Chair*†; James C. Blankenship, MD, FACC, FSCAI, Vice Chair*‡; Steven R. Bailey, MD, FACC, FSCAI*‡; John A. Bittl, MD,(More)
PURPOSE To evaluate carboplatin, etoposide, and bleomycin (JEB) in children with malignant extracranial germ cell tumors (GCTs). PATIENTS AND METHODS Malignant GCTs in children aged 0 to 16 years(More)
The American College of Cardiology Foundation (ACCF), Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, and the American Association for Thoracic Surgery, along(More)